AbbVie
ABBV
#26
Rank
A$601.55 B
Marketcap
A$340.36
Share price
-1.15%
Change (1 day)
28.04%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of September 2025 : -A$3.92 Billion

According to AbbVie's latest financial reports the company has -A$3.92 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$5.40 B-64.56%
2023-12-31$A$15.26 B-39.93%
2022-12-31$A$25.40 B19.31%
2021-12-31$A$21.29 B25%
2020-12-31$A$17.03 B-245.93%
2019-12-31$-A$11.68 Billion-2.65%
2018-12-31$-A$11.99 Billion-283.64%
2017-12-31$A$6.52 B1.51%
2016-12-31$A$6.43 B18.77%
2015-12-31$A$5.41 B154.41%
2014-12-31$A$2.12 B-57.73%
2013-12-31$A$5.03 B55.62%
2012-12-31$A$3.23 B-72.19%
2011-12-31$A$11.63 B-24.72%
2010-12-31$A$15.45 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
A$140.15 B-3,681.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$28.00 B-815.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.90 B-1,017.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.48 B-470.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$32.30 B-925.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$27.41 B-800.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$31.88 B-914.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
A$69.20 B-1,868.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$4.52 B-215.57%๐Ÿ‡บ๐Ÿ‡ธ USA